Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus
Abstract Background Middle East respiratory syndrome (MERS) is caused by a coronavirus (MERS‐CoV) and is characterized by hypoxemic respiratory failure. The objective of this study is to compare the outcomes of MERS-CoV patients before and after the availability of extracorporeal membrane oxygenation (ECMO) as a rescue therapy in severely hypoxemic patients who failed conventional strategies. Methods We collected data retrospectively on MERS-CoV patients with refractory respiratory failure from April 2014 to December 2015 in 5 intensive care units (ICUs) in Saudi Arabia. Patients were classified into two groups: ECMO versus conventional therapy. Our primary outcome was in-hospital mortality; secondary outcomes included ICU and hospital length of stay. Results Thirty-five patients were included; 17 received ECMO and 18 received conventional therapy. Both groups had similar baseline characteristics. The ECMO group had lower in-hospital mortality (65 vs. 100%, P = 0.02), longer ICU stay (median 25 vs. 8 days, respectively, P < 0.01), and similar hospital stay (median 41 vs. 31 days, P = 0.421). In addition, patients in the ECMO group had better PaO2/FiO2 at days 7 and 14 of admission to the ICU (124 vs. 63, and 138 vs. 36, P < 0.05), and less use of norepinephrine at days 1 and 14 (29 vs. 80%; and 36 vs. 93%, P < 0.05). Conclusions ECMO use, as a rescue therapy, was associated with lower mortality in MERS patients with refractory hypoxemia. The results of this, largest to date, support the use of ECMO as a rescue therapy in patients with severe MERS-CoV..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
|---|---|
| Enthalten in: |
Annals of Intensive Care - 8(2018), 1, Seite 10 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Mohammed S. Alshahrani [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Coronavirus infection |
|---|
| doi: |
10.1186/s13613-017-0350-x |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ045060169 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ045060169 | ||
| 003 | DE-627 | ||
| 005 | 20230308090210.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230227s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s13613-017-0350-x |2 doi | |
| 035 | |a (DE-627)DOAJ045060169 | ||
| 035 | |a (DE-599)DOAJ3ccbf2573b2745428837f9dd1a1d8e03 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RC86-88.9 | |
| 100 | 0 | |a Mohammed S. Alshahrani |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract Background Middle East respiratory syndrome (MERS) is caused by a coronavirus (MERS‐CoV) and is characterized by hypoxemic respiratory failure. The objective of this study is to compare the outcomes of MERS-CoV patients before and after the availability of extracorporeal membrane oxygenation (ECMO) as a rescue therapy in severely hypoxemic patients who failed conventional strategies. Methods We collected data retrospectively on MERS-CoV patients with refractory respiratory failure from April 2014 to December 2015 in 5 intensive care units (ICUs) in Saudi Arabia. Patients were classified into two groups: ECMO versus conventional therapy. Our primary outcome was in-hospital mortality; secondary outcomes included ICU and hospital length of stay. Results Thirty-five patients were included; 17 received ECMO and 18 received conventional therapy. Both groups had similar baseline characteristics. The ECMO group had lower in-hospital mortality (65 vs. 100%, P = 0.02), longer ICU stay (median 25 vs. 8 days, respectively, P < 0.01), and similar hospital stay (median 41 vs. 31 days, P = 0.421). In addition, patients in the ECMO group had better PaO2/FiO2 at days 7 and 14 of admission to the ICU (124 vs. 63, and 138 vs. 36, P < 0.05), and less use of norepinephrine at days 1 and 14 (29 vs. 80%; and 36 vs. 93%, P < 0.05). Conclusions ECMO use, as a rescue therapy, was associated with lower mortality in MERS patients with refractory hypoxemia. The results of this, largest to date, support the use of ECMO as a rescue therapy in patients with severe MERS-CoV. | ||
| 650 | 4 | |a Coronavirus infection | |
| 650 | 4 | |a Extracorporeal membrane oxygenation | |
| 650 | 4 | |a Rescue therapy | |
| 650 | 4 | |a Signs and symptoms respiratory | |
| 653 | 0 | |a Medical emergencies. Critical care. Intensive care. First aid | |
| 700 | 0 | |a Anees Sindi |e verfasserin |4 aut | |
| 700 | 0 | |a Fayez Alshamsi |e verfasserin |4 aut | |
| 700 | 0 | |a Awad Al-Omari |e verfasserin |4 aut | |
| 700 | 0 | |a Mohamed El Tahan |e verfasserin |4 aut | |
| 700 | 0 | |a Bayan Alahmadi |e verfasserin |4 aut | |
| 700 | 0 | |a Ahmed Zein |e verfasserin |4 aut | |
| 700 | 0 | |a Naif Khatani |e verfasserin |4 aut | |
| 700 | 0 | |a Fahad Al-Hameed |e verfasserin |4 aut | |
| 700 | 0 | |a Sultan Alamri |e verfasserin |4 aut | |
| 700 | 0 | |a Mohammed Abdelzaher |e verfasserin |4 aut | |
| 700 | 0 | |a Amenah Alghamdi |e verfasserin |4 aut | |
| 700 | 0 | |a Faisal Alfousan |e verfasserin |4 aut | |
| 700 | 0 | |a Adel Tash |e verfasserin |4 aut | |
| 700 | 0 | |a Wail Tashkandi |e verfasserin |4 aut | |
| 700 | 0 | |a Rajaa Alraddadi |e verfasserin |4 aut | |
| 700 | 0 | |a Kim Lewis |e verfasserin |4 aut | |
| 700 | 0 | |a Mohammed Badawee |e verfasserin |4 aut | |
| 700 | 0 | |a Yaseen M. Arabi |e verfasserin |4 aut | |
| 700 | 0 | |a Eddy Fan |e verfasserin |4 aut | |
| 700 | 0 | |a Waleed Alhazzani |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Annals of Intensive Care |d SpringerOpen, 2012 |g 8(2018), 1, Seite 10 |w (DE-627)DOAJ000122203 |x 21105820 |7 nnns |
| 773 | 1 | 8 | |g volume:8 |g year:2018 |g number:1 |g pages:10 |
| 856 | 4 | 0 | |u https://doi.org/10.1186/s13613-017-0350-x |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/3ccbf2573b2745428837f9dd1a1d8e03 |z kostenfrei |
| 856 | 4 | 0 | |u http://link.springer.com/article/10.1186/s13613-017-0350-x |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2110-5820 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 8 |j 2018 |e 1 |h 10 | ||